M A O'Rourke - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

M A O'Rourke

Showing results (1-10 of 10) with videos related to

Pageof 1

Sort By:

Seminars in Oncology|October 1, 1994

Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factorJ Crawford, M A O'Rourke

Clinics in Geriatric Medicine|November 1, 1987

Lung cancer in the elderlyM A O'Rourke, J Crawford

JAMA|August 21, 1987

Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderlyM A O'Rourke, J R Feussner, P Feigl, et al.

International Journal of Peptide and Protein Research|January 1, 1979

Reduction of beta-endorphin content in the rat pituitary after dehydration and adrenalectomyL F Tseng, M A O'Rourke, C H Li, et al.

Investigational New Drugs|January 1, 1997

Phase II trial to topotecan in hepatocellular carcinoma: a Southwest Oncology Group studyJ G Wall, J K Benedetti, M A O'Rourke, et al.

American Journal of Clinical Oncology|August 1, 1996

Phase II evaluation of ifosfamide/mesna in metastatic prostate cancer. A Southwest Oncology Group studyS K Williamson, M K Wolf, M A Eisenberger, et al.

Molecular Pharmacology|March 1, 1982

Potentiation of opiate action in neuroblastoma N18TG2 cells by lipid incorporationP Y Law, T D Nicksic, M A O'Rourke, et al.

Cancer Investigation|March 4, 2000

A phase II study of 9-aminocamptothecin in patients with refractory breast cancerE H Kraut, S P Balcerzak, D Young, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994

Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association studyH B Muss, L D Case, J N Atkins, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2000

Multicenter phase II study to evaluate a 28-day regimen of oral fluorouracil plus eniluracil in the treatment of patients with previously untreated metastatic colorectal cancerS Mani, H Hochster, T Beck, et al.

Pageof 1

Search research articles

Showing results (1-10 of 10) with videos related to

Sort By:

Pageof 1

Seminars in Oncology|October 1, 1994

Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factorJ Crawford, M A O'Rourke

Clinics in Geriatric Medicine|November 1, 1987

Lung cancer in the elderlyM A O'Rourke, J Crawford

JAMA|August 21, 1987

Age trends of lung cancer stage at diagnosis. Implications for lung cancer screening in the elderlyM A O'Rourke, J R Feussner, P Feigl, et al.

International Journal of Peptide and Protein Research|January 1, 1979

Reduction of beta-endorphin content in the rat pituitary after dehydration and adrenalectomyL F Tseng, M A O'Rourke, C H Li, et al.

Investigational New Drugs|January 1, 1997

Phase II trial to topotecan in hepatocellular carcinoma: a Southwest Oncology Group studyJ G Wall, J K Benedetti, M A O'Rourke, et al.

American Journal of Clinical Oncology|August 1, 1996

Phase II evaluation of ifosfamide/mesna in metastatic prostate cancer. A Southwest Oncology Group studyS K Williamson, M K Wolf, M A Eisenberger, et al.

Molecular Pharmacology|March 1, 1982

Potentiation of opiate action in neuroblastoma N18TG2 cells by lipid incorporationP Y Law, T D Nicksic, M A O'Rourke, et al.

Cancer Investigation|March 4, 2000

A phase II study of 9-aminocamptothecin in patients with refractory breast cancerE H Kraut, S P Balcerzak, D Young, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994

Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association studyH B Muss, L D Case, J N Atkins, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2000

Multicenter phase II study to evaluate a 28-day regimen of oral fluorouracil plus eniluracil in the treatment of patients with previously untreated metastatic colorectal cancerS Mani, H Hochster, T Beck, et al.

Pageof 1